Today, a Director at NewLink, Ernest Talarico, exercised options of NewLink (NASDAQ: NLNK) for $66.54K. The options were close to expired and Ernest Talarico disposed stocks.
See today’s analyst top recommended stocks >>
Currently, NewLink has an average volume of 227.7K.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians.
